DaVita Inc. (NYSE:DVA) Receives Average Rating of "Hold" from Brokerages

DaVita Inc. (NYSE:DVA - Get Free Report) has received a consensus rating of "Hold" from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $164.50.

A number of research firms have recently issued reports on DVA. Truist Financial dropped their price target on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. UMB Bank n.a. increased its position in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management purchased a new position in shares of DaVita during the fourth quarter worth about $30,000. National Pension Service boosted its stake in DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company's stock worth $30,000 after buying an additional 84 shares in the last quarter. Y.D. More Investments Ltd bought a new stake in DaVita in the first quarter valued at approximately $35,000. Finally, Coppell Advisory Solutions LLC grew its stake in DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after purchasing an additional 100 shares during the period. Institutional investors own 90.12% of the company's stock.

DaVita Stock Down 1.2%

NYSE:DVA traded down $1.71 during trading hours on Friday, reaching $139.45. 676,235 shares of the stock were exchanged, compared to its average volume of 810,129. The stock has a market cap of $10.53 billion, a PE ratio of 13.82, a PEG ratio of 0.97 and a beta of 1.11. DaVita has a twelve month low of $131.76 and a twelve month high of $179.60. The firm has a 50 day moving average of $140.11 and a 200 day moving average of $148.56. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same period in the previous year, the company posted $2.26 earnings per share. The business's revenue was up 5.0% on a year-over-year basis. On average, equities analysts expect that DaVita will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.